I'm in cycle two of this study. Iberdomide has already been reduced to .75mg because of neutropenia. Anyone else in this study?
Interested in more discussions like this? Go to the Blood Cancers & Disorders Support Group.
Welcome @shelleyf, Can you share more information about what the study is for?
Is the IDEAL study you are referring to the one to improve the way doctors identify and manage patients at risk of cardiovascular disease, including conditions such as heart attack or stroke?
Connect with thousands of patients and caregivers for support and answers.
Already have an account? Sign In